Selected research
Industry Research
Hypnotics and Sedatives Industry Research Report 2026
Market perspective
The global Hypnotics and Sedatives market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Hypnotics and Sedatives is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Hypnotics and Sedatives is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Hypnotics and Sedatives is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Hypnotics and Sedatives include Abbott, Takeda, Sanofi, Novartis, Mylan, Pfizer, Fresenius Kabi, Baxter and Sands Pharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Hypnotics and Sedatives market in terms of revenue (US$ million) and, where applicable, sales volume (k tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hypnotics and Sedatives Market by Company
Abbott
Takeda
Sanofi
Novartis
Mylan
Pfizer
Fresenius Kabi
Baxter
Sands Pharm
Hospira
Cobalt Laboratories
Hypnotics and Sedatives Segment by Type
Capsule
Solution
Suppository
Injectable
Hypnotics and Sedatives Segment by Application
Hospital
Clinic
Hypnotics and Sedatives Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hypnotics and Sedatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hypnotics and Sedatives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hypnotics and Sedatives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hypnotics and Sedatives manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hypnotics and Sedatives by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hypnotics and Sedatives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Capsule
- Solution
- Suppository
- Injectable
Applications
- Hospital
- Clinic
Companies covered
- Abbott
- Takeda
- Sanofi
- Novartis
- Mylan
- Pfizer
- Fresenius Kabi
- Baxter
- Sands Pharm
- Hospira
- Cobalt Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Hypnotics and Sedatives Market Size (2021-2032)
- 2.2.2 Global Hypnotics and Sedatives Sales (2021-2032)
- 2.2.3 Global Hypnotics and Sedatives Market Average Price (2021-2032)
- 2.3 Hypnotics and Sedatives by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Capsule
- 2.3.3 Solution
- 2.3.4 Suppository
- 2.3.5 Injectable
- 2.4 Hypnotics and Sedatives by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Hypnotics and Sedatives Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Hypnotics and Sedatives Sales (k tons) of Manufacturers (2021-2026)
- 3.3 Global Hypnotics and Sedatives Revenue of Manufacturers (2021-2026)
- 3.4 Global Hypnotics and Sedatives Average Price by Manufacturers (2021-2026)
- 3.5 Global Hypnotics and Sedatives Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Hypnotics and Sedatives, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Hypnotics and Sedatives, Product Type & Application
- 3.8 Global Manufacturers of Hypnotics and Sedatives, Established Date
- 3.9 Global Hypnotics and Sedatives Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abbott
- 4.1.1 Abbott Company Information
- 4.1.2 Abbott Business Overview
- 4.1.3 Abbott Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Abbott Hypnotics and Sedatives Product Portfolio
- 4.1.5 Abbott Recent Developments
- 4.2 Takeda
- 4.2.1 Takeda Company Information
- 4.2.2 Takeda Business Overview
- 4.2.3 Takeda Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Takeda Hypnotics and Sedatives Product Portfolio
- 4.2.5 Takeda Recent Developments
- 4.3 Sanofi
- 4.3.1 Sanofi Company Information
- 4.3.2 Sanofi Business Overview
- 4.3.3 Sanofi Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sanofi Hypnotics and Sedatives Product Portfolio
- 4.3.5 Sanofi Recent Developments
- 4.4 Novartis
- 4.4.1 Novartis Company Information
- 4.4.2 Novartis Business Overview
- 4.4.3 Novartis Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Novartis Hypnotics and Sedatives Product Portfolio
- 4.4.5 Novartis Recent Developments
- 4.5 Mylan
- 4.5.1 Mylan Company Information
- 4.5.2 Mylan Business Overview
- 4.5.3 Mylan Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Mylan Hypnotics and Sedatives Product Portfolio
- 4.5.5 Mylan Recent Developments
- 4.6 Pfizer
- 4.6.1 Pfizer Company Information
- 4.6.2 Pfizer Business Overview
- 4.6.3 Pfizer Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pfizer Hypnotics and Sedatives Product Portfolio
- 4.6.5 Pfizer Recent Developments
- 4.7 Fresenius Kabi
- 4.7.1 Fresenius Kabi Company Information
- 4.7.2 Fresenius Kabi Business Overview
- 4.7.3 Fresenius Kabi Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Fresenius Kabi Hypnotics and Sedatives Product Portfolio
- 4.7.5 Fresenius Kabi Recent Developments
- 4.8 Baxter
- 4.8.1 Baxter Company Information
- 4.8.2 Baxter Business Overview
- 4.8.3 Baxter Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Baxter Hypnotics and Sedatives Product Portfolio
- 4.8.5 Baxter Recent Developments
- 4.9 Sands Pharm
- 4.9.1 Sands Pharm Company Information
- 4.9.2 Sands Pharm Business Overview
- 4.9.3 Sands Pharm Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sands Pharm Hypnotics and Sedatives Product Portfolio
- 4.9.5 Sands Pharm Recent Developments
- 4.10 Hospira
- 4.10.1 Hospira Company Information
- 4.10.2 Hospira Business Overview
- 4.10.3 Hospira Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Hospira Hypnotics and Sedatives Product Portfolio
- 4.10.5 Hospira Recent Developments
- 4.11 Cobalt Laboratories
- 4.11.1 Cobalt Laboratories Company Information
- 4.11.2 Cobalt Laboratories Business Overview
- 4.11.3 Cobalt Laboratories Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Cobalt Laboratories Hypnotics and Sedatives Product Portfolio
- 4.11.5 Cobalt Laboratories Recent Developments
5 Global Hypnotics and Sedatives Market Scenario by Region
- 5.1 Global Hypnotics and Sedatives Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Hypnotics and Sedatives Sales by Region: 2021-2032
- 5.2.1 Global Hypnotics and Sedatives Sales by Region: 2021-2026
- 5.2.2 Global Hypnotics and Sedatives Sales by Region: 2027-2032
- 5.3 Global Hypnotics and Sedatives Revenue by Region: 2021-2032
- 5.3.1 Global Hypnotics and Sedatives Revenue by Region: 2021-2026
- 5.3.2 Global Hypnotics and Sedatives Revenue by Region: 2027-2032
- 5.4 North America Hypnotics and Sedatives Market Facts & Figures by Country
- 5.4.1 North America Hypnotics and Sedatives Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Hypnotics and Sedatives Sales by Country (2021-2032)
- 5.4.3 North America Hypnotics and Sedatives Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Hypnotics and Sedatives Market Facts & Figures by Country
- 5.5.1 Europe Hypnotics and Sedatives Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Hypnotics and Sedatives Sales by Country (2021-2032)
- 5.5.3 Europe Hypnotics and Sedatives Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Hypnotics and Sedatives Market Facts & Figures by Country
- 5.6.1 Asia Pacific Hypnotics and Sedatives Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Hypnotics and Sedatives Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Hypnotics and Sedatives Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Hypnotics and Sedatives Market Facts & Figures by Country
- 5.7.1 South America Hypnotics and Sedatives Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Hypnotics and Sedatives Sales by Country (2021-2032)
- 5.7.3 South America Hypnotics and Sedatives Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Hypnotics and Sedatives Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Hypnotics and Sedatives Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Hypnotics and Sedatives Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Hypnotics and Sedatives Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Hypnotics and Sedatives Sales by Type (2021-2032)
- 6.1.1 Global Hypnotics and Sedatives Sales by Type (2021-2032) & (k tons)
- 6.1.2 Global Hypnotics and Sedatives Sales Market Share by Type (2021-2032)
- 6.2 Global Hypnotics and Sedatives Revenue by Type (2021-2032)
- 6.2.1 Global Hypnotics and Sedatives Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Hypnotics and Sedatives Revenue Market Share by Type (2021-2032)
- 6.3 Global Hypnotics and Sedatives Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Hypnotics and Sedatives Sales by Application (2021-2032)
- 7.1.1 Global Hypnotics and Sedatives Sales by Application (2021-2032) & (k tons)
- 7.1.2 Global Hypnotics and Sedatives Sales Market Share by Application (2021-2032)
- 7.2 Global Hypnotics and Sedatives Revenue by Application (2021-2032)
- 7.2.1 Global Hypnotics and Sedatives Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Hypnotics and Sedatives Revenue Market Share by Application (2021-2032)
- 7.3 Global Hypnotics and Sedatives Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Hypnotics and Sedatives Value Chain Analysis
- 8.1.1 Hypnotics and Sedatives Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Hypnotics and Sedatives Production Mode & Process
- 8.2 Hypnotics and Sedatives Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Hypnotics and Sedatives Distributors
- 8.2.3 Hypnotics and Sedatives Customers
9 Global Hypnotics and Sedatives Analyzing Market Dynamics
- 9.1 Hypnotics and Sedatives Industry Trends
- 9.2 Hypnotics and Sedatives Industry Drivers
- 9.3 Hypnotics and Sedatives Industry Opportunities and Challenges
- 9.4 Hypnotics and Sedatives Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst